Piramal Pharma Clarifies Ontario Funding Not Material

Piramal Pharma Limited has clarified a news item regarding a $1.7 million investment from the Government of Ontario for its Aurora facility. The funding, received under the Life Sciences Scale-Up Fund (LSSUF), is intended for infrastructure upgrades, modernization, and sustainability initiatives. Piramal Pharma stated that this funding does not constitute a material event requiring disclosure under SEBI regulations, as it is not expected to have a significant impact on the company's operations, financial position, or performance. The company also noted that any share price or volume movement is likely due to market dynamics, and they are unaware of any specific reasons for such fluctuations.